Skip to main content

Table 2 Correlation analysis between leukocyte apoptosis markers and disease activity and steroid dosage in patients with systemic lupus erythematosus

From: Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic lupus erythematosus

 

SLE diseases activity

Steroid dosage

 

r

p

r

p

CD4+ cell Annexin V (%)

0.02

0.93

0.01

0.96

CD4+ cell Annexin V + 7AAD (%)

-0.09

0.70

-0.33

0.12

CD8+ cell Annexin V (%)

-0.30

0.19

-0.17

0.45

CD8+ cell Annexin V + 7AAD (%)

-0.06

0.79

-0.19

0.39

CD19+ cell Annexin V (%)

0.17

0.46

-0.19

0.39

CD19+ cell Annexin V + 7AAD (%)

0.12

0.61

-0.15

0.50

Monocyte Annexin V (%)

0.01

0.97

-0.11

0.54

Monocyte Annexin V + 7AAD (%)

0.04

0.85

-0.14

0.46

APO2.7 CD4+ cell (%)

0.17

0.51

-0.29

0.20

APO2.7 CD8+ cell (%)

0.32

0.19

-0.12

0.61

APO2.7 CD19+ cell (%)

0.59

0.01*

0.17

0.46

APO2.7 monocyte (%)

0.05

0.77

-0.17

0.35

  1. Abbreviations: r, correlation coefficient; p, p value; SLEDAI, Systemic lupus erythematosus disease activity index 2000.
  2. *p < 0.05.